BRENT L SAUNDERS
CIK 1268854 · Chairman of the Board and CEO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.87M
Companies
11
Total Filings
75
Lifetime Open-Market Net
$1.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLCO | Chairman of the Board and CEO | 978,389 | $15.08 | $14.75M | $1.01M | 12 | 2026-05-26 |
| SPRY | Director | 0 | $9.76 | $0 | -$1.71M | 5 | 2025-06-27 |
| SKIN | Director | 7,676,591 | $0.65 | $5.02M | $406.1K | 10 | 2025-06-18 |
| CSCO | Director | 24,143 | $121.10 | $2.92M | $0 | 7 | 2022-12-12 |
| BBIO | Director | 17,600 | $66.80 | $1.18M | $254.9K | 4 | 2022-06-24 |
| Allergan plc (AGN) Delisted | Chairman, President and CEO | 0 | — | — | $756.2K | 8 | 2020-05-11 |
| Allergan plc (AGNpA) Delisted | Chairman, President and CEO | 177,631 | — | — | $2.07M | 12 | 2018-01-02 |
| Allergan plc (ACTpA) Delisted | CEO and President | 131,862 | — | — | $0 | 2 | 2015-05-19 |
| Forest Laboratories, LLC (FRX) Delisted | CEO & President | 0 | $12.00 | $0 | $0 | 5 | 2014-07-02 |
| Merck & Co., Inc. (SGPpB) Delisted | Senior Vice President | 50,783 | — | — | $0 | 6 | 2009-11-04 |
| Merck & Co., Inc. (SGPpM) Delisted | Senior Vice President | 21,459 | — | — | -$1.12M | 2 | 2007-05-03 |
Recent Filings · Page 6 of 8
75 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-04 | Allergan plc (AGNpA) Delisted | Grant (A) | +27,978 | $6.65M | EDGAR |
| 2017-03-14 | CSCO | Grant (A) | +4,728 | $0 | EDGAR |
| 2016-11-21 | Allergan plc (AGNpA) Delisted | Buy (P) | +5,250 | $992.9K | EDGAR |
| 2016-10-03 | Allergan plc (AGNpA) Delisted | Tax (F) | −7,587 | -$1.75M | EDGAR |
| 2016-08-17 | Allergan plc (AGNpA) Delisted | Tax (F) | −108 | -$27.4K | EDGAR |
| 2016-07-05 | Allergan plc (AGNpA) Delisted | Tax (F) | −16,266 | -$3.76M | EDGAR |
| 2015-10-05 | Allergan plc (AGNpA) Delisted | Tax (F) | −7,587 | -$2.14M | EDGAR |
| 2015-08-24 | Allergan plc (AGNpA) Delisted | Buy (P) | +1,000 | $301.9K | EDGAR |
| 2015-05-19 | Allergan plc (ACTpA) Delisted | Tax (F) | −3,449 | -$1.02M | EDGAR |
| 2015-03-31 | Allergan plc (ACTpA) Delisted | Grant (A) | +135,507 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.